SDC4 and breast carcinoma: Mechanistically, BPzoledronic acid exhibits an anti-breast cancer effect, namely the inhibition of cell proliferation, adhesion, migration, and invasion via the suppression of the expression of SDC1 and 2, whereas SDC4 was upregulated [175].